|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-12-29
|
|
pubmed:abstractText |
A pentavalent, bovine-derived rotavirus vaccine (RotaTeq, Merck) was licensed in 2006 for use in infants. A previously licensed rotavirus vaccine was withdrawn due to elevated risk of intussusception. We prospectively evaluated the risk of intussusception and other pre-specified adverse events among RotaTeq recipients in the Vaccine Safety Datalink.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1532-0987
|
|
pubmed:author |
pubmed-author:BaggsJamesJ,
pubmed-author:BelongiaEdward AEA,
pubmed-author:IrvingStephanie ASA,
pubmed-author:KulldorffMartinM,
pubmed-author:LewisEdwinE,
pubmed-author:LieuTracy ATA,
pubmed-author:ShuiIrene MIM,
pubmed-author:TranJ VJV,
pubmed-author:Vaccine Safety Datalink Investigation Group,
pubmed-author:WeintraubEricE,
pubmed-author:YihW KatherineWK,
pubmed-author:YinRuihuaR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1-5
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine.
|
|
pubmed:affiliation |
Marshfield Clinic Research Foundation, Epidemiology Research Center (ML2), 1000 North Oak Ave, Marshfield, WI 54449, USA. belongia.edward@marshfieldclinic.org
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
